O. Bender Et Al. , "Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation," ARCHIV DER PHARMAZIE , vol.2022, no.e2200407, pp.1-20, 2022
Bender, O. Et Al. 2022. Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation. ARCHIV DER PHARMAZIE , vol.2022, no.e2200407 , 1-20.
Bender, O., Shoman, M. E., Ali, T. F. S., Dogan, R., Çelik, İ., Mollica, A., ... Hamed, M. I. A.(2022). Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation. ARCHIV DER PHARMAZIE , vol.2022, no.e2200407, 1-20.
Bender, Onur Et Al. "Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation," ARCHIV DER PHARMAZIE , vol.2022, no.e2200407, 1-20, 2022
Bender, Onur Et Al. "Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation." ARCHIV DER PHARMAZIE , vol.2022, no.e2200407, pp.1-20, 2022
Bender, O. Et Al. (2022) . "Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation." ARCHIV DER PHARMAZIE , vol.2022, no.e2200407, pp.1-20.
@article{article, author={Onur Bender Et Al. }, title={Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation}, journal={ARCHIV DER PHARMAZIE}, year=2022, pages={1-20} }